Dr. Nicola Normanno
Director, Translational Research,
National Cancer Institute, Italy
Pascale Foundation

 

Dr. Normanno, MD earned his Medical Doctor Degree in 1988 at the Medical School, University of Naples (Italy) Federico II. After a residency in Oncology at the Oncology Department of the same university, in 1991 he achieved the specialisation in Medical Oncology, and in 2001 in Haematology.

Dr. Normanno will present the experience of his laboratory evaluating the Ion Torrent Oncomine Comprehensive Assay Plus*, a targeted NGS approach that can help clinical research in identifying all relevant biomarkers now including also HRD.

You May Also Like

View our free, on-demand webinar series to learn about the Oncomine Comprehensive Assay Plus.

Clinical Research on Genomic Profiling with Comprehensive Assay Plus

Dr. Ines Raineri, Institute for Surgical Pathology, University Hospital and University of Zurich, Switzerland

 

Comprehensive Genome Profiling Using the Oncomine™ Comprehensive Assay Plus

Dr. Philip Martin Jermann, Director Molecular Assay Development, University Hospital Basel

 

Multicentric Study to Evaluate In-house Solution for CGP

Dr. Massimo Barberis, Director of Histopathology and Molecular Diagnostics Unit, European Institute of Oncology, Italy

Ready To Learn More?

Ask our NGS experts any questions or subscribe to get helpful updates from our team, including whitepapers, webinars, videos, case studies and more!